We found that ADLL, ALL and ADL significantly improved ataxia when symptomatic Npc1−/− mice were treated acutely for 7 days; this is in agreement with observational studies in NPC1 patients (Bremova et al., 2015) treated with ADLL, using the same dosage per kg and day. Here, NPC1 is linked to cerebellar ataxia.